A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma | |
Sheng, Xinan; Cui, Chuanliang; Mao, Lili; Chi, Zhihong; Si, Lu; Kong, Yan; Li, Siming; Lian, Bin; Gu, Kangsheng; Tao, Min | |
刊名 | MOLECULAR THERAPY
![]() |
2013 | |
卷号 | 21期号:7 |
ISSN号 | 1525-0016 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3448776 |
专题 | 昆明医科大学 |
推荐引用方式 GB/T 7714 | Sheng, Xinan,Cui, Chuanliang,Mao, Lili,et al. A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma[J]. MOLECULAR THERAPY,2013,21(7). |
APA | Sheng, Xinan.,Cui, Chuanliang.,Mao, Lili.,Chi, Zhihong.,Si, Lu.,...&Guo, Jun.(2013).A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma.MOLECULAR THERAPY,21(7). |
MLA | Sheng, Xinan,et al."A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma".MOLECULAR THERAPY 21.7(2013). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论